NK News
Archived Headlines
- The biotech breakdown on valuation and returns: Large biotechs outperform smaller peers 07/28/15
- NantKwest prices upsized IPO at $25, well above the range; largest biotech IPO ever with $2.6 billion market cap 07/27/15
- Week ahead: 10 IPOs set to price during the week of July 27 07/27/15
- Genetically engineered cancer killers: NantKwest sets terms for $151 million IPO 07/16/15
- Natural born cancer killers: Conkwest files for a $173 million IPO 06/19/15
Cloud-based healthcare: NantHealth sets terms for $91 million IPO
NantHealth, which provides cloud-based healthcare data solutions to support clinical decisions, announced terms for its IPO on Tuesday. The Culver City, CA-based company plans to raise $91 million by offering 6.5 million shares at a price range of $12.50 to...read more
Renaissance Capital's 3Q 2015 Quarterly US IPO Market Review
US IPO Market Contracts as Returns Slump in the Third Quarter The IPO market slowed in the 3Q 2015 to 34 deals, down 43% year-over-year, hurt by the broad market sell-off and specific sector conditions, including a near absence of tech and energy issuance. In...read more
US IPO Weekly Recap: "Breaking" news in the IPO market as most deals end down
Breaking news: Two-thirds of this week's IPOs broke issue. Last week, we noted that the recent stretch of strong first-day pops (+26%) with weak follow-through performance (-3%) was likely unsustainable. This week, IPOs averaged a loss of 1% on the first day ...read more
July IPO activity was below average; will August outperform expectations?
17 IPOs in July raised $2.8 billion in proceeds, falling far short of the 33 IPOs that raised $8.2 billion in July 2014. Year-to-date, 121 companies have gone public in 2015, a 33% drop from the 180 that had priced through July 2014. August...read more